BBS8 Antibodies

Santa Cruz Biotechnology features a diverse variety of BBS8 monoclonal antibodies for investigating BBS8 in cellular processes. BBS8 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BBS8, a member of the Bardet-Biedl syndrome (BBS) protein family, plays a crucial role in ciliary function and cellular signaling pathways. Mutations in the BBS8 gene have been linked to BBS, a genetic disorder characterized by obesity, retinal degeneration, and polydactyly. Research has shown that BBS8 is essential for proper cilia formation and maintenance. Understanding BBS8 function provides valuable insights into ciliary-related diseases. Current studies focus on how BBS8 interacts with other proteins in the BBSome complex. Ongoing research explores the potential therapeutic implications of targeting BBS8 in various disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of BBS8 and its role in human health.